| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Goldman Sachs analyst Scott Fidel maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from $2...
UBS analyst Kevin Caliendo maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from $180 to $170.
Cantor Fitzgerald analyst Sarah James maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from...
Barclays analyst Andrew Mok downgrades Molina Healthcare (NYSE:MOH) from Equal-Weight to Underweight and lowers the price ta...
US healthcare insurance providers Centene and Oscar Health stocks are down after Molina Healthcare reported disappointing guida...